World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
65
Citations
12341
World Ranking
2876
National Ranking
1357

Rene J. Duquesnoy publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Rene J. Duquesnoy sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 347 publications — 73rd percentile

73% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Rene J. Duquesnoy D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Rene J. Duquesnoy sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 65 D-Index — 43rd percentile

43% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Rene J. Duquesnoy is affiliated with the University of Pittsburgh in the United States. Their research primarily spans the fields of Immunology and Microbiology as well as Medicine, with a focused interest in subfields such as Immunology, Transplantation, Surgery, Molecular Biology, and Nephrology.

The scientist's work addresses various topics including T-cell and B-cell Immunology, Renal Transplantation Outcomes and Treatments, Immunotherapy and Immune Responses, Renal Diseases and Glomerulopathies, the Complement system in diseases, and Transplantation methods and outcomes as well as Organ Transplantation techniques and outcomes.

Key recent papers authored or co-authored by Rene J. Duquesnoy include:

  • "High-throughput sequencing defines donor and recipient HLA B-cell epitope frequencies for prospective matching in transplantation" (2021, Communications Biology)
  • "Eplet-Based HLA Class II Matching for Transplantation: Design of a Repertoire of Interlocus Eplets Shared between HLA-DR, -DQ and -DP Alleles" (2020, OBM Transplantation)
  • "Autobiographical perspectives on HLA epitopes: Past, present and future" (2022, Human Immunology)
  • "Adaptation of HLA testing to characterize the cynomolgus macaque MHC polymorphisms and alloantibody signatures" (2023, HLA)
  • "Immunogenetics of heteroclitic recognition of HLA-DQB1 55R eplet specificity by human alloantibody" (2021, Human Immunology)

Frequent publication venues for their work include:

  • Human Immunology
  • Communications Biology
  • OBM Transplantation
  • HLA

Rene J. Duquesnoy has collaborated with several researchers repeatedly, notably Steven G. E. Marsh, Jane Kearns, Malek Kamoun, Jenny Tran, and Oliver P. Günther.

Best Publications

  • Obliterative bronchiolitis after lung and heart-lung transplantation: An analysis of risk factors and management

    Ko Bando;Irvin L. Paradis;Shari Similo;Hiroaki Konishi

  • A structurally based approach to determine HLA compatibility at the humoral immune level.

    Rene J. Duquesnoy

  • HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. I. Description of the algorithm.

    René J Duquesnoy

  • A1, Cw7, B8, DR3 HLA antigen combination associated with rapid decline of T-helper lymphocytes in HIV-1 infection. A report from the Multicenter AIDS Cohort Study.

    R. A. Kaslow;M. vanRaden;H. Friedman;R. Duquesnoy

  • Clonal dominance among T-lymphocyte infiltrates in arthritis.

    Ivan Stamenkovic;Michele Stegagno;Kathryn A. Wright;Stephen M. Krane

  • The acceptable mismatch program as a fast tool for highly sensitized patients awaiting a cadaveric kidney transplantation: short waiting time and excellent graft outcome.

    Frans H. J. Claas;Marian D. Witvliet;René J. Duquesnoy;Guido G. Persijn

  • Serum autoantibody to the nucleolar antigen PM-Scl. Clinical and immunogenetic associations.

    Chester V. Oddis;Yutaka Okano;William A. Rudert;Massimo Trucco

  • HLAMatchmaker: A Molecularly Based Algorithm for Histocompatibility Determination. V. Eplet Matching for HLA-DR, HLA-DQ, and HLA-DP

    Rene J. Duquesnoy;Medhat Askar

  • Successful transfusion of platelets “mismatched” for HLA antigens to alloimmunized thrombocytopenic patients

    René J. Duquesnoy;René J. Duquesnoy;Donald J. Filip;Glenn E. Rodey;Alfred A. Rimm

  • Human intestinal Vdelta1+ lymphocytes recognize tumor cells of epithelial origin.

    M. J. Maeurer;D. Martin;W. Walter;Kaihong Liu

  • HLA-Specific Antibodies are Risk Factors for Lymphocytic Bronchiolitis and Chronic Lung Allograft Dysfunction

    Alin L. Girnita;Rene Duquesnoy;Samuel A. Yousem;Aldo T. Iacono

  • De novo anti-HLA antibody after pandemic H1N1 and seasonal influenza immunization in kidney transplant recipients.

    I. Katerinis;K. Hadaya;R. Duquesnoy;S. Ferrari-Lacraz

  • The number of amino acid triplet differences between patient and donor is predictive for the antibody reactivity against mismatched human leukocyte antigens.

    Marlies K. A. Dankers;Marian D. Witvliet;Dave L. Roelen;Peter De Lange

  • HLA-specific antibodies are associated with high-grade and persistent-recurrent lung allograft acute rejection.

    Alin L. Girnita;Kenneth R. McCurry;Aldo T. Iacono;Rene Duquesnoy

  • HLAmatchmaker: a molecularly based algorithm for histocompatibility determination. III. Effect of matching at the HLA-A,B amino acid triplet level on kidney transplant survival.

    Rene J. Duquesnoy;Steve Takemoto;Peter de Lange;Ilias I. N. Doxiadis

  • HLA mismatching increases the risk of BK virus nephropathy in renal transplant recipients.

    Yehia Awadalla;Parmjeet Randhawa;Kris Ruppert;Adriana Zeevi

  • HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. II. Verification of the algorithm and determination of the relative immunogenicity of amino acid triplet-defined epitopes.

    René J Duquesnoy;Marilyn Marrari

  • Immunologically mediated disease of the airways after pulmonary transplantation

    Bartley P. Griffith;Irvin L. Paradis;Adriana Zeevi;Hanna Rabinowich

  • The Influence Of Hla Matching On Cytomegalovirus Hepatitis And Chronic Rejection After Liver Transplantation

    R Mañez;L T White;P Linden;S Kusne

  • Long-term outcome of human leukocyte antigen mismatching in liver transplantation: results of the National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database.

    Vijayan Balan;Kris Ruppert;A. Jake Demetris;Tatiana Ledneva

  • Serum analysis after transplant nephrectomy reveals restricted antibody specificity patterns against structurally defined HLA class I mismatches

    Oyedele A. Adeyi;Alin L. Girnita;Judy Howe;Marilyn Marrari

Frequent Co-Authors

Adriana Zeevi
Adriana Zeevi University of Pittsburgh
Frans H.J. Claas
Frans H.J. Claas Leiden University Medical Center
Arend Mulder
Arend Mulder Leiden University Medical Center
Thomas E. Starzl
Thomas E. Starzl University of Pittsburgh
Robert L. Hardesty
Robert L. Hardesty University of Pittsburgh
Anthony J. Demetris
Anthony J. Demetris University of Pittsburgh
John J. Fung
John J. Fung University of Chicago
Robert L. Kormos
Robert L. Kormos University of Pittsburgh
William H. Hildebrand
William H. Hildebrand University of Oklahoma Health Sciences Center
Ilias I.N. Doxiadis
Ilias I.N. Doxiadis Leiden University Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, advancing your nursing education can open doors to specialized healthcare roles. Many professionals start by exploring 12-month accelerated nursing programs, which offer a fast track to a Bachelor of Science in Nursing (BSN). These programs are ideal for career changers looking to enter the nursing field quickly.

Once you have a foundational nursing degree, consider enrolling in accelerated RN to NP programs. These online degrees are designed for registered nurses aiming to become nurse practitioners, blending advanced clinical skills with leadership training.

For those without a nursing background, there are online ADN programs for non nurses that allow direct entry into nursing practice. These flexible formats help meet the increasing demand for healthcare professionals specialized in immunological care.

Finally, if you are a Family Nurse Practitioner (FNP) seeking to specialize further, transitioning to acute care might be your next step. Learning how to go from fnp to acute care np can enhance your expertise in managing critical and complex patient conditions, making you a vital asset in immunology-related fields.

Best Scientists Citing Rene J. Duquesnoy

Trending Scientists

Recently Published Articles